ian_c_johnston Profile Banner
Ian Johnston Profile
Ian Johnston

@ian_c_johnston

Followers
1K
Following
2K
Media
43
Statuses
776

Paris correspondent @FT Got a story? šŸ“§: [email protected]. I've mostly moved to Bluesky: https://t.co/Q7hpd2I64U

Paris
Joined September 2013
Don't wanna be here? Send us removal request.
@ian_c_johnston
Ian Johnston
5 months
RT @alicemhancock: I thought I was reading a similar thing about the EU not so long ago. @ENGIEgroup CEO tells @ian_c_johnston that the….
Tweet card summary image
ft.com
Comments by French energy group chief follow Trump’s decision to pause hundreds of billions of dollars of green funds
0
1
0
@ian_c_johnston
Ian Johnston
7 months
RT @Mij_Europe: Great profile of @bayrou by @labboudles @hallbenjamin @ian_c_johnston ā€˜The original centrist’: France’s new prime minister….
Tweet card summary image
ft.com
An early Macron ally and admirer of Henri IV, FranƧois Bayrou will have to navigate parliamentary turmoil
0
8
0
@ian_c_johnston
Ian Johnston
8 months
RT @samjoiner: NEW: Are the robots finally coming?. In our latest visual story, @upyorkshire @sam_learner @inari_ta @ian_bott_artist @Mikep….
0
15
0
@ian_c_johnston
Ian Johnston
9 months
RT @amy_borrett: Do Gen Z have it harder than any other generation? I dug into the data on housing, jobs and mental health for @FT to see i….
Tweet card summary image
ft.com
Young Britons are finding it harder than ever before to achieve financial independence — here’s why
0
4
0
@ian_c_johnston
Ian Johnston
9 months
"Customers pay to spit into a tube, mail it back and learn what is written in their genes. the problem is that after the big reveal, there is not much scope for recurring business". Sharp follow-up to our piece on 23andMe's problems from FT's Lex:.
Tweet card summary image
ft.com
Was it nature or nurture? In the unhappy case of a DNA testing company and its sliding share price, the answer is both
0
0
0
@ian_c_johnston
Ian Johnston
9 months
23andMe was the toast of Silicon Valley in 2021. Now lawyers suing it over a data breach of 7mn users want a cut-price compensation deal before it runs out of cash. Story on the genetics testing company with @stephistacey and @GeorgeNHammond:.
Tweet card summary image
ft.com
Once-hyped genetic testing company hit by data breach, plunging share price and board resignations
1
5
2
@ian_c_johnston
Ian Johnston
10 months
RT @mroliverbarnes: Ladies and gentlemen, @FT data genius @jburnmurdoch has called it: weight loss drugs are causing a fall in obesity rate….
0
112
0
@ian_c_johnston
Ian Johnston
10 months
RT @FT: Roche data shows stomach-churning side effects of weight-loss drugs
Tweet card summary image
ft.com
High rates of vomiting among those who took strong doses in trials have unsettled investors
0
28
0
@ian_c_johnston
Ian Johnston
11 months
RT @mroliverbarnes: Haunting quote: ā€œPancreatic cancer does not have patient advocates because they all die,ā€ said Julie Fleshman, chief ex….
Tweet card summary image
ft.com
The first in an FT series looking at the new energy behind the fight for cancer cures
0
30
0
@ian_c_johnston
Ian Johnston
11 months
RT @mroliverbarnes: A little known tale: Swiss pharma group Roche, which is pitching itself to investors as a new weight loss contender, pa….
0
7
0
@ian_c_johnston
Ian Johnston
11 months
RT @ftenergy: How Big Tech is quietly trying to reshape how pollution is reported
ft.com
Critics say a proposed change could allow large energy users to hide their true emissions
0
22
0
@ian_c_johnston
Ian Johnston
11 months
AstraZeneca vaccine project in doubt as UK Treasury seeks to cut state aid . via @ft.
Tweet card summary image
ft.com
Merseyside plant had been offered £65mn for redevelopment but review looks to reduce figure to £40mn
0
1
1
@ian_c_johnston
Ian Johnston
11 months
RT @AndyBounds: EU warned new medical trial rules will slow approval of vital treatments via @FT with ⁦@ian_c_johnston⁩. .
Tweet card summary image
ft.com
Pharma groups and patients say guidance prioritising mass trials threaten drug development
0
2
0
@ian_c_johnston
Ian Johnston
1 year
RT @Laura_K_Hughes: A rising number of women are seeking private IVF treatments in England as the NHS rolls back funding for fertility serv….
0
5
0
@ian_c_johnston
Ian Johnston
1 year
RT @samjoiner: NEW: Inside the race to make the world’s fastest running shoes. We worked with @lumafield to CT-scan the latest Nike and A….
0
30
0
@ian_c_johnston
Ian Johnston
1 year
AstraZeneca calls on Labour to change rules on innovative drug pricing . Stretched healthcare systems are assessing whether they can afford the high cost of innovative new treatments that have boosted pharmaceutical companies’ sales. via @ft.
Tweet card summary image
ft.com
Pascal Soriot criticises decision to block breast cancer drug in England as FTSE 100 group raises profit outlook
0
0
1
@ian_c_johnston
Ian Johnston
1 year
More FT pharma new: US recommendations for the world's first RSV vaccines will shrink their sales, in a blow to jab makers GSK, Pfizer and Moderna . via @ft.
Tweet card summary image
ft.com
Pharma groups could see almost threefold drop in demand due to US health official decision, says Airfinity
0
1
1
@ian_c_johnston
Ian Johnston
1 year
The NHS has prescribed weight loss drug Wegovy far less than expected since its UK launch, leaving patients on waiting lists while wealthier users pay out of pocket šŸ’‰. New in ⁦@FT⁩ with ⁦@clara__murray⁩
Tweet card summary image
ft.com
Long waiting list for drug because of shortage of specialist services could hit patients unable to pay privately
0
3
2
@ian_c_johnston
Ian Johnston
1 year
RT @HenryJFoy: Von der Leyen commission unlawfully concealed Covid vaccine contracts details, court finds, in legal blow to her crunch re-e….
Tweet card summary image
ft.com
EU court rules that European Commission unlawfully withheld information about procurement
0
7
0
@ian_c_johnston
Ian Johnston
1 year
Great read from @akilazoe on a worrying legacy of France's elections: . "The campaign emboldened extremists at a time when tensions in French society were already running high. Minorities were the first to pay the price". via @financialtimes.
0
2
4